Behavioral Health Business October 6, 2023
The federal government will extend COVID-era telehealth flexibilities until December 2024, dramatically extending the runway for the Drug Enforcement Administration (DEA) to establish new rules for using telehealth and controlled substances.
The DEA and U.S. Department of Health and Human Services released a new temporary rule on Oct. 6 after conducting two days of listening sessions about how best to regulate telehealth and controlled substances in the post-COVID era. The DEA expects to release a new rule regulating telehealth and controlled substances in about a year.
During the pandemic, the federal government extended temporary flexibilities that allowed for telehealth services of many types — but especially medication-assisted treatment providers — to thrive. These COVID-era rules demonstrated that telehealth treatment...
Today's Sponsors
Today's Sponsor